Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC) - 06/02/26
, Romain Boulestreau b, Victor Aboyans c, Sophie Béliard d, Franck Boccara e, Bertrand Cariou f, Sybil Charrière g, h, Philippe Moulin g, h, Bruno Vergès a, Rene Valero d, Antonio Gallo iKeywords : Dyslipidemia, LDL-cholesterol, Consensus statement, Cardiovascular risk, Cardiovascular mortality, Lipid-lowering treatment
Plan
| ☆ | These guidelines were developed by the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC) and jointly published in Annales d'endocrinologie, Diabetes and Metabolism and Archives of Cardiovascular Diseases by Elsevier Masson SAS. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
